. METUPUK ANNUAL REPORT NOVEMBER 2021-APRIL 2023 Irq ## **First Annual Report (9 November 2021 - 5 April 2023)** METUPUK (Metastatic Exchange to Unleash Power UK) Charity number 1196494 Registered address 11 Lower Knoll Road Diggle Oldham OL3 5PD METUPUK is registered by the Charity Commission of England and Wales. Registration date 9 November 2021. ## **Structure** METUPUK is a Foundation Charitable Incorporated Organisation registered by the Charity Commission of England and Wales. ## **Objects** The relief of patients in the UK who have or are at risk of metastatic breast cancer (MBC); in particular (but not exclusively) through raising awareness about MBC by the provision of information and education, working with stakeholders to increase MBC research and access to drugs and ensuring for the public benefit that MBC patient treatment and care remains a national priority. ## **What the charity does:** General Charitable Purposes The Advancement Of Health Or Saving Of Lives ## **Who the charity helps:** The General Public/mankind ## **How the charity helps:** Provides Advocacy/advice/information ## **Where the charity operates:** Throughout England And Wales Northern Ireland Scotland **“I am delighted that METUPUK has completed our first 16 months as a registered charity. Looking back, it is amazing to see how far our organisation has come since I first set it up in 2016.”** ## **Jo Taylor, METUPUK Founder and Chair** The seeds of METUPUK were planted in 2015, when a group of women in the United States came together to campaign for better awareness and treatment options for metastatic breast cancer (MBC). Unfortunately, little has changed between then and now, and metastatic breast cancer still has poor outcomes because data is not collected and we are not counted when we are alive. Around 30% of people with breast cancer can expect to develop MBC, defined as when breast cancer spreads in the body beyond the breast and nearby lymph nodes. Some are diagnosed with de novo metastatic breast cancer, when spread is found at the same time as first diagnosis. For others, it can occur at any time, including up to 20 or 30 years after a primary diagnosis. We have no reliable UK data on MBC, but in the US, median life expectancy is between 2-5 years depending on sub-type, and at five years after diagnosis just 31%* of people are expected to be alive. Since our beginnings in 2016 and our registration as a charity in 2021, METUPUK has grown as a patient advocacy organisation. Many amazing patients joined our cause and helped to formulate our strategy. Most of these women who supported us in the early days have now died, but the METUPUK of today stands on their shoulders. We had passionate fundraisers whose generosity and drive gave our charity an opening bank balance of £13,800 when we registered in November 2021. At the end of our first year as a charity, our closing balance was over £62,000. We are incredibly grateful to all our generous donors and hardworking fundraisers. In this report we shall outline how these funds have been used to further our charitable purposes. *https://seer.cancer.gov/statfacts/html/breast-subtypes.html 3 The 16 month period which forms our first financial year has seen the Charity lose too many volunteers from metastatic breast cancer. Our board of Trustees has lost two members, and we are shaped by their influence and mourn the loss of them. **LOUISE FURNEAUX** Trustee, Secretary Died September 2022 **CONNIE JOHNCOCK** Trustee, Treasurer Died March 2023 We rely on the work of our Trustees and also our patient advocate volunteers. None of us draw a salary from the Charity and METUPUK would not function without all the people who freely give their time and expertise. I thank everyone who has helped us become the organisation that we are today. A 2-3 year median life expectancy for MBC is not a statistic to rejoice but rather a demonstration of how much more needs to be done. **JO TAYLOR** Founder/Chair METUPUK "I am passionate about creating change for patients especially those with MBC. The only way change will happen is for us to demand change together as a group. We cannot continue with the same outcomes and with women dying at the same rate." 4 ## OUR PEOPLE Trustees during financial period 9 November 2021- 5 April 2023 were Jo Taylor (Chair), Andy Figgins, Constance Johncock (Treasurer, died March 2023), Helen Steele, Julia Bradford, Louise Furneax (Secretary, died September 2022) and Madeleine Meynell. **----- Start of picture text -----**
JO ANDY DR HELEN
TAYLOR FIGGINS STEELE
Founder/Chair Trustee - Friends and Trustee - Research and
METUPUK Family Support Clinical Trials
**----- End of picture text -----**
**----- Start of picture text -----**
JULIA BRADFORD MADELEINE MEYNELL
Trustee - Trustee -
Internal Operations Access to Drugs
**----- End of picture text -----**
5 ## **Trustee Recruitment** Founding Trustees were recruited from volunteers of the METUPUK precursor organisation and worked together to create the Charity. Our constitution requires at least one trustee to have metastatic breast cancer. New Trustees are elected by the board of trustees where a skill shortage has been identified. We have a trustee with responsibility for the induction of new trustees, and each trustee is provided with a copy of The Essential Trustee. **"Without our dedicated and amazing volunteers we wouldn’t have been able to acheive the breadth and reach of our work this year. They are at the heart of METUPUK"** Helen Steele, Volunteer Manager, Trustee A proportion of our funds are spent on providing trustees and volunteers with the tools to be effective advocates. These include but are not limited to: Marketing information for events. ie. printed documentation, roller banners, equipment, stand costs. - Funding patient advocates travel to attend meetings to represent METUPUK because volunteers are located across the UK. - Funding IT/telephone costs for our website and secure Microsoft document storage. - Providing trustees and volunteers email addresses and access to SharePoint and Microsoft 365. We do not have any paid staff but we do use external suppliers on an ad-hoc basis for website maintenance, campaigns and to produce a monthly newsletter. 6 ## OUR AIMS ## AND OBJECTIVES Our Strategy in our first financial year is summarised across three main areas; **Awareness and Education** , **Research and Access to Drugs** and **Patient Treatment and Care.** These were formulated with the intention of providing benefit to the public and to patients with MBC. ## AWARENESS AND EDUCATION ## **METUPUK Aims and Objectives:** MBC is currently incurable. We highlight the harsh reality of MBC which is not well reflected in the ‘pink’ celebratory campaigns. Alongside increasing public awareness, we challenge and educate policy makers, charities and government bodies to ensure that MBC is a priority for funding, research and innovation. We work to ensure that MBC is represented on all Trusts or Boards of breast cancer organisations, ideally by patient advocates being included as Trustees or Board Members. We work with Cancer Alliances and Health Boards to ensure primary breast cancer patients are provided with the tools and information to understand and recognise the symptoms of MBC. This encourages earlier MBC diagnosis and earlier treatment, thereby improving quality of life and survival prospects. During this financial year we have run two major awareness campaigns; **Darker Pink** and **True Crimes** . ## **DARKER PINK** The Darker Side of Pink’ is a physical interactive experience which highlights the seriousness of Metastatic Breast Cancer - the biggest killer of women aged 35-64 7 with cancer in the UK. The impactful exhibition features 31 life-size transparent figures, depicting the invisibility of the disease – each one representing **a woman who dies every day** in the UK. The exhibition is part of a drive to raise awareness of the issues and struggles faced by women living with metastatic breast cancer and the urgent need for better care and research. Each 'Darker Pink' figure features a QR code that, when scanned, plays a video from a real-life woman living with secondary breast cancer. Filmed in 2021, many of these women have since died, themselves becoming a statistic they spoke about whilst also campaigning for change. The exhibition has been placed in public spaces such as libraries, community centres and retail spaces across England and Scotland during our first year. With the sponsorship of Debbie Abrahams MP for Oldham East and Saddleworth, in March 2023 the Dark Pink exhibition was displayed in the Houses of Parliament (see image on front over). Patient advocates were available daily to speak to MPs and members of the House of Lords to explain to decision makers the issues that patients living with MBC face. We intend in the coming year to display the Darker Pink figures in Wales, along with locations in Northern Ireland, because we are committed to supporting all patients across the UK. 8 ## **TRUE CRIMES** In Breast Cancer Awareness month 2022, we created a TV advert to complement the Darker Pink exhibition which was still touring the UK. Created and produced by Break Creative Partners, with support and assistance from Millk Media in Manchester, the hard hitting 30 second video was originally scripted and planned to be released across social media channels, but a partnership with media company Guerillascope, saw the advert being shown on mainstream TV across the UK on the 13th October 2022. Voiced by **Maxine Peake** , it was seen on over 40 spots across 10 channels including ITV, Channel 5 and MTV, reaching an actual total audience of over 2 million. Programmes included Gok Wan, Jamie Oliver, Jeremy Vine, The Great British Bake Off, and prime spots in Emmerdale who were running a MBC story at the time. This elevated our campaign to a large of people with a hard hitting message in keeping with the #DarkerPink messages. Both the Darker Pink Exhibition and the True Crimes advert provide education about metastatic breast cancer for the public benefit. They complement each other, with the Darker Pink exhibition providing in depth information about metastatic breast cancer, and True Crimes providing short form information to millions of people as a TV advert and a social media clip. All of our campaigns were combined with dissemination of the ABCD Red Flag Infographics for ductal and lobular breast cancer. These infographics highlight the signs and symptoms of metastatic breast cancer and are signposted by NHS England to educate patients and the public. ## **Watch the True Crimes TV advert with Maxine Peak** 9 It's not fvn knawlng th¢rt we feel invisible orKI ttNJt rK) ¢y* 1$ listenirK4 io U >T¢4 ft'¥ not fvn knowlng that so muny of us 0￿ untswo of tho red flogs symptoms. Mary MBta#atrEMobfCunc•r OARKER $IDE OF •Daik•vPlrth' $DEOF Il* not fun knowlng that 's o stwgle to occess any Igdng NHS m8rn01 supwi. It* not fun knowlnq that re doesrft seem to be a test to $how who 1$ or wtentiolly whg isn't goSng to be cured. Klrttin Sp*h¢•r M•t¢stotiC 81è051 Con¢•i DARKE IIDI OF DARKER SIDE OF •Dovk•rPI It's not lun kTr￿￿Tr9 that m plannir¥J my fvneral. It's rsot somethlng thot ot 39 rs be ¢SJiTra. It's not lun knowlrbg that I'm less likely to access clSnicol triols becouse I toke other medication. M*¥rAII M*ta*tat￿8T￿￿tClj￿L*r DARKER SIOE OF •Dar DIOF It's not lun knawlng th¢rt hod to self fvjnd treotments os there wos nothing else approved on the NHS 0voila￿e to me. It's fvn knowln4 thui don't even have clinical trals bos•d on black women's experiences. mBtastat￿￿TaCI5tcDnc@r OAJIKER SIDÉ OF •Davk•r SIDEOF io ## RESEARCH AND ACCESS TO DRUGS ## **METUPUK Aims and Objectives:** - Work with life science companies to increase the number of MBC trials in line with the MBC number of patients, recognising the real potential to extend and save their lives. - Work to make breast cancer trials more accessible to patients with MBC. - Submit evidence to the National Institute for Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC) to speed up the drug approval process for new drug treatments for MBC. - Maximise technological advances to improve collation and analysis of data and statistics for MBC. - Encourage decision makers to use information to better inform treatment decisions. ## **IMPROVING ACCESS TO DRUGS** Drug access is one of the key objectives of METUPUK because new drugs are needed to increase survival outcomes for patients with MBC. To achieve this we work as stakeholders with NICE and the SMC who are responsible for ensuring that drugs and medical devices are value for money for the NHS. We bring the patient voice into the drug approvals process. All our written submissions are written in collaboration with patients who have the subtype of metastatic breast cancer being reviewed in relation to the proposed drug. We also send patient advocates to speak directly to the committees. The committees are dominated by health economists, scientists and drug companies, and so it is important for these decision-makers to hear from the patients who will benefit from the technology being appraised. 11 A number of drugs for MBC were approved during our first financial year. METUPUK was a stakeholder participating in the following drug approvals: - **Trodelvy (NICE and SMC)** - **Pembrolizumab plus chemo (NICE and SMC)** - **Tucatinib combination (NICE and SMC)** - **Enhertu third line (NICE and SMC)** - **Piqray plus fulvestrant (NICE)** All of these campaigns bring vital additional drug options to women and men with MBC in the UK. A campaign we would particularly like to highlight is the approval of **Trodelvy (sacituzumab govitecan)** , an antibody drug conjugate licensed to treat unresectable or metastatic triple negative breast cancer. Trodelvy was granted accelerated approval by the United States and was subsequently licenced in the UK under Project Orbis. Project Orbis was designed to deliver faster access to innovative cancer treatments, but this did not include the health technology appraisal which could take up to a year. METUPUK patient advocate Dr Philippa Hetherington had triple negative metastatic breast cancer and understood that patients did not have that long to wait. Philippa started the #TrodelvyNow campaign to get Gilead, the manufacturer of Trodelvy, to introduce a named basis pre-reimbursement scheme so that patients could start on the drug before NICE/SMC approval was completed. Much of Philippa’s advocacy was done while paralysed from a spinal cord compression and having to deal with a very different new normal. . Most of the drugs accepted for use on the NHS this year were made available by both NICE and the SMC. An exception to this was the combination Piqray plus fulvestrant which was not accepted by the SMC and therefore is not available to MBC patients in Scotland treated within the NHS. This discrepancy shows that unequal access to cancer drugs remains within the UK. We intend to open up discussions with the drug company to discuss if resubmission to the SMC is possible, as part of next year’s planned work. 12 ## **CLINICAL TRIALS** Our work on facilitating access to clinical trials builds on the work started by METUPUK patient advocate Beth Roberts in 2018. She constructed a clinical trials spreadsheet to help patients searching for MBC trials. She recognised that the large clinical trial databases were not fit for purpose, and the large organisations that should have been keeping them up to date were not. Trials were missing, trials that had stopped recruiting were being advertised as still open, trials available for MBC patients were not tagged so not appearing in the correct searches. Beth died in 2020, and now one of our volunteers, Kat Southwell, has taken this role on. With an IT background, she is developing the trial listing as an interactive dashboard, to be further developed in the next financial year. We will also be collaborating with other third sector MBC organisations such as Make 2nds Count to produce the most up to date information for patients to use, wherever they live in the UK. 13 ## PATIENT TREATMENT AND CARE METUPUK campaigns to ensure that patients have access to the best treatment, so that patients can live longer and better. Our work with the drug regulatory bodies NICE and the SMC is an example of how we campaign for the most up to date treatments. We also campaign for better access to radiotherapy and surgery for patients with MBC. For example, Philippa Hetherington gave evidence to the Parliamentary Health and Social Care Committee in October 2021 about the challenges faced by NHS patients accessing the latest drugs and radiotherapy, and what role science and innovation can play in helping us to bridge the gap in survival rates between the UK and countries such as Australia and Denmark. Philippa had been denied stereotactic radiotherapy for her brain metastases and so had paid out of her own pocket for treatment. Her testimony demonstrated firsthand to legislators the fact that NHS patients do not have access to the most innovative treatments. An ongoing campaign has been for the provision of Clinical Nurse Specialists (CNS) dedicated to metastatic breast cancer. This campaign has particular traction in Wales, where patient advocate Tassia Haines has taken it all the way to the Senedd. During and prior to 2022, there was just one MBC CNS the whole of Wales. Tassia’s work has increased the number of CNS posts, but still not enough to cover every patient in Wales. Lack of dedicated CNS provision for patients with metastatic breast cancer is not just a problem in Wales. There is still much to be done to ensure that every patient has a dedicated nurse to support them at every stage of their illness. We also have an ongoing social media campaign about living well with metastatic breast cancer. Using the searchable hashtag #BusyLivingWithMets we highlight achievements made by people living with the disease, and use our social media channels to encourage living well. We do not endorse any “well being” activities that are not evidence based. 14 Our Chair Jo Taylor is passionate about the benefits exercise and fitness can bring to physical and mental health in cancer, and so are many of our volunteers. We also recognise the impact that metastatic breast cancer has on friends and family. We have a Friends and Family Facebook group which is moderated by Andy Figgins, who lost his wife Elaine to metastatic breast cancer. The group provides peer support in a safe environment. We do not provide a group for patients with metastatic breast cancer because we do not wish to replicate what is already provided by other organisations. We do signpost patients to groups run by other registered charities. ## OUR FINANCES ## **Financial Review** The Charity was registered on 9th November 2021, with a first financial year end of 5th April 2023. The Charity’s income for this period exceeded expenditure by £62k, leaving the Charity in a stable position at the end of the financial year. ## **Expenditure summary 2021-2023** The Charity’s funds have been used effectively and have been spent in line with our objectives. The largest item of expenditure was for attendance at events to further awareness of, and to provide education about, Metastatic Breast Cancer. ## **Income summary 2021-2023** For the financial period, the Charity’s main source of income was fundraising, comprising 85% of the total funding. The remaining 15% was from direct donations to the Charity. Income came from individuals and corporates as well as income generated through Charity-led fundraising activities. METUPUK is a registered charity in England and Wales (1196494) Registered office 11 Lower Knoll Road, Diggle, Oldham OL3 5PD 15 METUPUK.ORG.UK ## **Charity Reserves Policy** METUPUK holds a minimum of 12 months running costs in reserve from unrestricted funds. These running costs include IT/telephone costs including Microsoft accounts, website hosting and support, virtual assistant fees and the cost of running ongoing campaigns such as the Darker Pink exhibition. We also need to set aside provision for professional fees such as accountancy and legal advice should be charity be closed. The funding stream of METUPUK relies mainly on donations via funding platforms, which varies between month to month. Any funding via grants are generally restricted funds which cannot form part of the reserves policy. Our running costs vary according the number of active volunteers who require IT access and the cost of our campaigns. The reserve set for this year is £25,000, and this figure will be reviewed by the Trustees on an annual basis. ## **STATEMENT OF FINANCIAL ACTIVITIES** |**STATEMENT OF FINANCIAL ACTIVITIES**|**STATEMENT OF FINANCIAL ACTIVITIES**|**STATEMENT OF FINANCIAL ACTIVITIES**| |---|---|---| |**METUPUK**
**Charity no: 1196494**||| |**Income**||| |Fundraising||£73,044.38| |Donations||£13,823.83| |Other||£15.00| |||**£86,883.21**| |||| |**Charitable Activities Costs**||| |MBC Awareness / Education Events||£22,339.35| |Education/ Communications||£600.05| |Other costs||£660.32| |||**£23,599.72**| |**Governance Costs**||| |IT/Website/SM/Telecoms||£770.20| |Insurance||£179.32| |Legal & Governance Costs||£181.80| |||**£1,131.32**| |||| |**Incoming**||**£86,883.21**| |**Outgoing**||**£24,731.04**| |Closing Balance||**£62,152.17**| 16 |Charity Name METUPUK|Charity Name METUPUK|CharityNo|1196494|1196494|| |---|---|---|---|---|---| |||CompanyNo|||| |Annual accounts for theperiod|||||| |Period start date|**11/9/2021**|**To**|Period end
date|**4/5/2023**|| ## **Section A Statement of financial activities (including summary income and expenditure account)** |**Recommended categories by activity**
Guidance Note
**Income (Note 3)**
**Income and endowments from:**
Donations and legacies
S01
Charitable activities
S02
Other trading activities
S03
Investments
S04
Separate material item of income
S05
Other
S06
**_Total_**
S07
**Expenditure (Notes 6)**
**Expenditure on:**
Raising funds
S08
Charitable activities
S09
Separate material expense item
S10
Other
S11
**_Total_**
S12
S13
Tax payable
S14
S15
Net gains/(losses) on investments
S16
**Net income/(expenditure)**
S17
**Extraordinary items**
S18
**Transfers between funds**
S19
S20
Other gains/(losses)
S21
**_Net movement in funds_**
S22
Total funds brought forward
S23
**_Total funds carried forward_**
S24
**Net income/(expenditure) before tax for**
**the reporting period**
**Net income/(expenditure) after tax before**
**investment gains/(losses)**
**Other recognised** **gains/(losses):**
Gains and losses on revaluation of fixed assets for the
charity’s own use
**_Reconciliation of_**
**_funds:_**|**£**
**£**
**£**
F01
F02
F03
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**£**
**£**
**£**
F01
F02
F03
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**£**
**£**
**£**
F01
F02
F03
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**Total funds**
**£**
**£**
F04
F05

**Prior year**
**funds**|**Total funds**
**£**
**£**
F04
F05

**Prior year**
**funds**|**Total funds**
**£**
**£**
F04
F05

**Prior year**
**funds**| |---|---|---|---|---|---|---| ||13,824|-|-||13,824|-| ||73,044|-|-||73,044|-| ||-|-|-||-|-| ||-|-|-||-|-| ||-|-|-||-|-| ||15|-|-||15|-| ||86,883|-|-||86,883|-| |||||||| ||-|-|-||-|-| ||23,600|-|-||23,600|-| |||||||| ||1,131|-|-||1,131|-| ||24,731|-|-||24,731|-| |||||||| ||62,152|-|-||62,152|-| ||-|-|-||-|-| ||62,152|-|-||62,152|-| ||-|-|-||-|-| ||62,152|-|-||62,152|-| ||-|-|-||-|| ||-|-|-||-|-| |||||||| ||-|-|-||-|-| ||-|-|-||-|-| ||62,152|-|-||62,152|-| |||||||| ||-|-|-||-|-| ||62,152|-|-||62,152|-| Charity Name METUPUK Charity No 1196494 Company No ## **Section B Balance sheet** |Guidance Note
**Fixed assets**
**Intangible assets (Note 15)**
B01
**Tangible assets (Note 14)**
B02
**Heritage assets (Note 16)**
B03
**Investments (Note 17)**
B04
**_Total fixed assets_**
B05
**Current assets**
**Stocks (Note 18)**
B06
**Debtors (Note 19)**
B07
**Investments (Note 17.4)**
B08
**Cash at bank and in hand (Note 24)**
B09
**_Total current assets_**
B10
B11
**_Net current assets/(liabilities)_**
B12
**_Total assets less current liabilities_**
B13
B14
**Provisions for liabilities**
B15
**_Total net assets or liabilities_**
B16
**Funds of the Charity**
**Endowment funds (Note 27)**
B17
B18
**Unrestricted funds**
B19
**Revaluation reserve**
B20
**Fair value reserve**
B21
**_Total funds_**
B22
**Creditors: amounts falling due within**
**one year (Note 20)**
**Creditors: amounts falling due after**
**one year (Note 20)**
**Restricted income funds (Note 27)**|**£**
**£**
F01
F02
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**|**£**
**£**
F01
F02
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**|**£**
**£**
F03
F04
**Endowment**
**funds**
**Total this**
**year**|**£**
**£**
F03
F04
**Endowment**
**funds**
**Total this**
**year**|**£**
F05
**Total last**
**year**| |---|---|---|---|---|---| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||62,152|-|-|62,152|-| ||62,152|-|-|62,152|-| ||||||| ||-|-|-|-|-| ||||||| ||62,152|-|-|62,152|-| ||||||| ||62,152|-|**-**|62,152|-| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||||||| ||62,152|-|-|62,152|-| ||||||| ||-|||-
-
62,152
-|-| |||-|-||-| ||62,152||||-| ||||||| ||||||| ||62,152|-|-|62,152|-| Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable As per bank a Not applicable Not applicable _**The company was entitled to exemption from audit under s477 of the Companies Act 2006 relating to small companies.**_ _**The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.**_ _**The directors acknowledge their responsibilities for complying with the requirements of the Companies Act with respect to accounting records and the preparation of accounts.**_ _**These accounts have been prepared in accordance with the provisions applicable to small companies subject to the small companies regime and in accordance with FRS102 SORP.**_ |Signed by one or two trustees/directors on behalf of all the
trustees/directors|Print Name|Date of
approval
dd/mm/yyyy| |---|---|---| ||Jo Taylor|2/3/2024| ||Madeleine Meynell|**2/3/2024**| CC17a (Excel) 02/04/2024 2 |Signature of director authenticating accounts being sent to
Companies House|Signature|Date
dd/mm/yyyy| |---|---|---| ||#VALUE!|2/4/2024| ||Phil Southwell|**Print name**| CC17a (Excel) 02/04/2024 3 e e e e e CC17a (Excel) 02/04/2024 4 ## **Section C Notes to the accounts** ## Note 1 **Basis of preparation** _**This section should be completed by all charities** ._ ## **1.1 Basis of accounting** These accounts have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these accounts. The accounts have been prepared in accordance with: - the Statement of Recommended Practice: Accounting and Reporting by Charities - • and with* ü preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) issued on 16 July 2014 - • and with* ü the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) - and with the Charities Act 2011. The charity constitutes a public benefit entity as defined by FRS 102.* - -Tick as appropriate ## **1.2 Going concern** _**If there are material uncertainties related to events or conditions that cast significant doubt on the charity's ability to continue as a going concern, please provide the following details or state "Not applicable", if appropriate:**_ An explanation as to those factors that support _**Not applicable**_ the conclusion that the charity is a going concern; Disclosure of any uncertainties that make the _**Not applicable**_ going concern assumption doubtful; Where accounts are not prepared on a going _**Not applicable**_ concern basis, please disclose this fact together with the basis on which the trustees prepared the accounts and the reason why the charity is not regarded as a going concern. ## **1.3 Change of accounting policy** The accounts present a true and fair view and no changes have been made to the accounting policies adopted in note { }. |Yes*
No*|ü||* -Tick as appropriate|* -Tick as appropriate| |---|---|---|---|---| ||ü|||| |**_Please disclose:_**||||| |**_(i) the nature of the change in accounting policy;_**||||**_Not applicable_**| |**_(ii) the reasons why applying the new accounting policy_**
**_provides more reliable and more relevant information;_**
**_and_**||||**_Not applicable_**| CC17a (Excel) 02/04/2024 5 _**(iii) the amount of the adjustment for each line affected in the current period, each prior period presented and the aggregate amount of the adjustment relating to periods before those presented, 3.44 FRS102 SORP.**_ _**Not applicable**_ ## **1.4 Changes to accounting estimates** No changes to accounting estimates have occurred in the reporting period (3.46 FRS102 SORP). Yes* ü * -Tick as appropriate No* ü ## _**Please disclose:**_ |**_Please disclose:_**|| |---|---| |**_(i) the nature of any changes;_**|**_Not applicable_**| |**_(ii) the effect of the change on income and expense or_**
**_assets and liabilities for the current period; and_**|**_Not applicable_**| |**_(iii) where practicable, the effect of the change in one or_**
**_more future periods._**|**_Not applicable_**| ## **1.5 Material prior year errors** No material prior year error have been identified in the reporting period (3.47 FRS102 SORP). |Yes*
No*||ü|* -Tick as appropriate| |---|---|---|---| |||ü|| ||||| ## _**Please disclose:**_ |**_Please disclose:_**|| |---|---| |**_(i) the nature of the prior period error;_**|**_Not applicable_**| |**_(ii) for each prior period presented in the accounts, the_**
**_amount of the correction for each account line item_**
**_affected; and_**|**_Not applicable_**| |**_(iii) the amount of the correction at the beginning of the_**
**_earliest prior period presented in the accounts._**|**_Not applicable_**| CC17a (Excel) 02/04/2024 6 CC17a (Exte 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 2 Accounting policies** ## _**This standard list of accounting policies has been applied by the charity except for those deleted. Where a different or additional policy has been adopted then this is detailed in the box below.**_ **2.1 RECONCILIATION WITH PREVIOUS GENERALLY ACCEPTED ACCOUNTING PRACTICE** **----- Start of picture text -----**
||| |---|---| |Please provide a description| |of the nature of each change| |in accounting policy| |Reconciliation of funds per previous GAAP to funds determined under FRS 102| |Start of|End of| |period|period| |£|£| |Fund balances as previously| |stated| |Adjustments:| **----- End of picture text -----**
**Fund balance as restated** _**Reconciliation of net income/(net expenditure) per previous GAAP to net income/(net expenditure) under FRS 102**_ **End of period£ Net income/(expenditure) as previously stated** _**Adjustments:**_ **Previous period net income/(expenditure) as restated** CC17a (Excel) 02/04/2024 8 ## **Not applicable There are no differences** CC17a (Excel) 02/04/2024 9 ## **Section C Notes to the accounts (cont)** |**Note 2**|**Accounting policies**| |---|---| |**2.2 INCOME**|| |**Recognition of income**|These are included in the Statement of Financial Activities (SoFA) when:| ||· the charity becomes entitled to the resources;| ||· it is more likely than not that the trustees will receive the resources;| ||· the monetary value can be measured with sufficient reliability.| |**Offsetting**|There has been no offsetting of assets and liabilities, or income and expenses, unless
required or permitted by the FRS 102 SORP or FRS 102.| |**Grants and donations**|Grants and donations are only included in the SoFA when the general income
recognition criteria are met (5.10 to 5.12 FRS102 SORP).| ||In the case of performance related grants, income must only be recognised to the extent| ||that the charity has provided the specified goods or services as entitlement to the grant| ||only occurs when the performance related conditions are met (5.16 FRS 102 SORP).| ||Legacies are included in the SOFA when receipt is probable, that is, when there has| |**Legacies**|been grant of probate, the executors have established that there are sufficient assets in
the estate and any conditions attached to the legacy are either within the control of the| ||charity or have been met.| |**Government grants**|The charity has received government grants in the reporting period| ||Gift Aid receivable is included in income when there is a valid declaration from the donor.| |**Tax reclaims on**|Any Gift Aid amount recovered on a donation is considered to be part of that gift and is| |**donations and gifts**|treated as an addition to the same fund as the initial donation unless the donor or the| ||terms of the appeal have specified otherwise.| |**Contractual income and**|This is only included in the SoFA once the charity has provided the related goods or| |**performance related**|services or met the performance related conditions.| |**grants**|| |**Donated goods**|Donated goods are measured at fair value (the amount for which the asset could be
exchanged) unless impractical to do so.| ||The cost of any stock of goods donated for distribution to beneficiaries is deemed to be| ||the fair value of those gifts at the time of their receipt and they are recognised on receipt.| ||In the reporting period in which the stocks are distributed, they are recognised as an| ||expense at the carrying amount of the stocks at distribution.| ||Donated goods for resale are measured at fair value on initial recognition, which is the| ||expected proceeds from sale less the expected costs of sale, and recognised in 'Income| ||from other trading activities' with the corresponding stock recognised in the balance| ||sheet. On its sale the value of stock is charged against 'Income from other trading| ||activities' and the proceeds from sale are also recognised as 'Income from other trading| ||activities'.| ||Goods donated for on-going use by the charity are recognised as tangible fixed assets| ||and included in the SoFA as incoming resources when receivable.| ||Gifts in kind for use by the charity are included in the SoFA as income from donations| ||when receivable.| |**Donated services and**|Donated services and facilities are included in the SOFA when received at the value of| |**facilities**|the gift to the charity provided the value of the gift can be measured reliably.| ||Donated services and facilities that are consumed immediately are recognised as| ||income with an equivalent amount recognised as an expense under the appropriate| ||heading in the SOFA.| |**Support costs**|The charity has incurred expenditure on support costs.| |**Volunteer help**|The value of any voluntary help received is not included in the accounts but is described
in the trustees’ annual report.| |Yes*
No*
N/a*|Yes*
No*
N/a*|Yes*
No*
N/a*| |---|---|---| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| 02/04/2024 CC17 FRS 102 SORP 10 |**Income from interest,**|This is included in the accounts when receipt is probable and the amount receivable can| |---|---| |**royalties and dividends**|be measured reliably.| |**Income from membership**|
Membership subscriptions received in the nature of a gift are recognised in Donations| |**subscriptions**|and Legacies.| ||Membership subscriptions which gives a member the right to buy services or other| ||benefits are recognised as income earned from the provision of goods and services as| ||income from charitable activities.| |**Settlement of insurance**
**claims**|Insurance claims are only included in the SoFA when the general income recognition
criteria are met (5.10 to 5.12 FRS102 SORP) and are included as an item of other
income in the SoFA.| |**Investment gains and**
**losses**|This includes any realised or unrealised gains or losses on the sale of investments and
any gain or loss resulting from revaluing investments to market value at the end of the| ||year.| |**2.3 EXPENDITURE**|**AND LIABILITIES**| ||Liabilities are recognised where it is more likely than not that there is a legal or| |**Liability recognition**|constructive obligation committing the charity to pay out resources and the amount of the
obligation can be measured with reasonable certainty.| |**Governance and support**|Support costs have been allocated between governance costs and other support.| |**costs**|Governance costs comprise all costs involving public accountability of the charity and its| ||compliance with regulation and good practice.| ||Support costs include central functions and have been allocated to activity cost| ||categories on a basis consistent with the use of resources, eg allocating property costs| ||by floor areas, or per capita, staff costs by the time spent and other costs by their usage.| |**Grants with performance**|Where the charity gives a grant with conditions for its payment being a specific level of| |**conditions**|service or output to be provided, such grants are only recognised in the SoFA once the| ||recipient of the grant has provided the specified service or output.| |**Grants payable without**|Where there are no conditions attaching to the grant that enables the donor charity to| |**performance conditions**|realistically avoid the commitment, a liability for the full funding obligation must be| ||recognised.| |**Redundancy cost**|The charity made no redundancy payments during the reporting period.| |**Deferred income**|No material item of deferred income has been included in the accounts.| |**Creditors**|The charity has creditors which are measured at settlement amounts less any trade
discounts| ||A liability is measured on recognition at its historical cost and then subsequently| |**Provisions for liabilities**|measured at the best estimate of the amount required to settle the obligation at the| ||reporting date| |**Basic financial**
**instruments**|The charity accounts for basic financial instruments on initial recognition as per
paragraph 10.7 FRS102 SORP. Subsequent measurement is as per paragraphs 11.17
to 11.19, FRS102 SORP.| |**2.4 ASSETS**|| |**Tangible fixed assets for**|These are capitalised if they can be used for more than one year, and cost at least| |**use by charity**|| ||They are valued at cost.| ||The depreciation rates and methods used are disclosed in note 14.| ||The charity has intangible fixed assets, that is, non-monetary assets that do not have| |**Intangible fixed assets**|physical substance but are identifiable and are controlled by the charity through custody| ||or legal rights. The amortisation rates and methods used are disclosed in note 15.| ||They are valued at cost.| ||The charity has heritage assets, that is, non-monetary assets with historic, artistic,| ||scientific, technological, geophysical or environmental qualities that are held and| |**Heritage assets**|maintained principally for their contribution to knowledge and culture. The depreciation| ||rates and methods used as disclosed in note 16.| They are valued at cost. Fixed asset investments in quoted shares, traded bonds and similar investments are valued at initially at cost and subsequently at fair value (their market value) at the year end The same treatment is applied to unlisted investments unless fair value cannot be ## **Investments** |Yes*
No*
N/a*|Yes*
No*
N/a*|Yes*
No*
N/a*| |---|---|---| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |||| |||| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| 02/04/2024 CC17 FRS 102 SORP 11 end. The same treatment is applied to unlisted investments unless fair value cannot be measured reliably in which case it is measured at cost less impairment. Investments held for resale or pending their sale and cash and cash equivalents with a maturity date of less than 1 year are treated as current asset investments **Stocks and work in** Stocks held for sale as part of non-charitable trade are measured at the lower or cost or **progress** net realisable value. Goods or services provided as part of a charitable activity are measured at net realisable value based on the service potential provided by items of stock. Work in progress is valued at cost less any foreseeable loss that is likely to occur on the contract. Debtors (including trade debtors and loans receivable) are measured on initial **Debtors** recognition at settlement amount after any trade discounts or amount advanced by the charity. Subsequently, they are measured at the cash or other consideration expected to be received. The charity has investments which it holds for resale or pending their sale and cash and cash equivalents with a maturity date less than one year. These include cash on deposit **Current asset investments** and cash equivalents with a maturity of loss than one year held for investment purposes rather than to meet short-term cash commitments as they fall due. They are valued at fair value except where they qualify as basic financial instruments. |ü|ü|ü| |---|---|---| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| |Yes*
No*
N/a*||| |ü|ü|ü| ## **POLICIES ADOPTED ADDITIONAL TO OR DIFFERENT FROM THOSE ABOVE** 02/04/2024 CC17 FRS 102 SORP 12 **Section C Notes to the accounts (cont)** ## **Note 3 Income** |**Note 3 Income**|**Income**|**Income**|**Income**|**Income**|**Income**|**Income**| |---|---|---|---|---|---|---| |**Analysis of income**
**Total funds**
**Prior year**
**£**
**£**
Donations andgifts
13,824 - - 13,824 -
Gift Aid
- - - - -
Legacies
- - - - -
- - - - -
- - - -
Donatedgoods,facilities and services
- - - - -
Other
15 - - 15
**Total**13,839 - - 13,839 -
Fundraising events
73,044 - - 73,044 -
- - - - -
- - - - -
Other
- - - - -
**Total**73,044 - - 73,044 -
- - - - -
- - - - -
- - - - -
Other
- - - - -
**Total**- - - - -
Interest income
- - - - -
Dividend income
- - - - -
Rentalandleasingincome
- - - - -
Other
- - - - -
**Total**- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
**Total**- - - - -
**Other:**
Conversion of endowment funds into income
- - - - -
- - - - -
- - - - -
- - - - -
Other
- - - - -
**Total**- - - - -
**TOTAL INCOME**
86,883- -86,883-
**Other information:**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**
**Donations**
**and legacies:**
General grants provided by government/other
charities
Membership subscriptions and sponsorships
which are in substance donations
**Charitable**
**activities:**
**Other trading**
**activities:**
**Income from**
**investments:**
**Separate**
**material item**
**of income**
Gain on disposal of a tangible fixed asset held
for charity's own use
Gain on disposal of a programme related
investment
Royalties from the exploitation of intellectual
propertyrights|**Analysis of income**
**Total funds**
**Prior year**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|||||| ||Donations andgifts|13,824|-|-|13,824|-| ||Gift Aid|-|-|-|-|-| ||Legacies|-|-|-|-|-| ||General grants provided by government/other
charities|-|-|-|-|-| ||Membership subscriptions and sponsorships
which are in substance donations|-|-|-|-|| ||Donatedgoods,facilities and services|-|-|-|-|-| ||Other|15|-|-|15|| ||**Total**|13,839|-|-|13,839|-| |||||||| ||Fundraising events|73,044|-|-|73,044|-| |||-|-|-|-|-| |||-|-|-|-|-| ||Other|-|-|-|-|-| ||**Total**|73,044|-|-|73,044|-| |||||||| |||-|-|-|-|-| |||-|-|-|-|-| |||-|-|-|-|-| ||Other|-|-|-|-|-| ||**Total**|-|-|-|-|-| |||||||| ||Interest income|-|-|-|-|-| ||Dividend income|-|-|-|-|-| ||Rentalandleasingincome|-|-|-|-|-| ||Other|-|-|-|-|-| ||**Total**|-|-|-|-|-| |||||||| |||-|-|-|-|-| |||-|-|-|-|-| |||-|-|-|-|-| |||-|-|-|-|-| ||**Total**|-|-|-|-|-| |||||||| ||Conversion of endowment funds into income|-|-|-|-|-| ||Gain on disposal of a tangible fixed asset held
for charity's own use|-|-|-|-|-| ||Gain on disposal of a programme related
investment|-|-|-|-|-| ||Royalties from the exploitation of intellectual
propertyrights|-|-|-|-|-| ||Other|-|-|-|-|-| ||**Total**|-|-|-|-|-| |||||||| |||86,883|-|-|86,883|-| |||||||| |**All income in the prior year was unrestricted except for: (please**
**provide description and amounts)**||**_Not applicable_**
||||| |**Where any endowment fund is converted into income in the**
**reporting period, please give the reason for the conversion.**
**Where any endowment fund is converted into income in the**
**prior period, please give the reason for the conversion.**||||||| |||**_Not applicable_**||||| |||||||| |||**_Not applicable_**||||| |||||||| |**Within the income items above the following items are material:**
**(please disclose the nature, amount and any prior year**
**amounts)**||**_Not applicable_**
||||| |||||||| |**This year: Where sums originally denominated in foreign**
**currency have been included in income, explain the basis on**
**which those sums have been translated into sterling (or the**
**currency in which the accounts are drawn up).**||**_Not applicable_**||||| CC17 (E l) 02/04/2024 13 _**Not applicable**_ **Last year: Where sums originally denominated in foreign currency have been included in income, explain the basis on which those sums have been translated into sterling (or the currency in which the accounts are drawn up).** CC17 (E l) 02/04/2024 14 **Section C Notes to the accounts (cont)** ## **Note 4 Analysis of receipts of government grants** |**Government grant 1**
**Government grant 2**
**Government grant 3**
**Other**
**Government grant 1**
**Government grant 2**
**Government grant 3**
**Other**
**_Please provide details of any_**
**_unfulfilled conditions and other_**
**_contingencies attaching to grants that_**
**_have been recognised in income._**
**_Please give details of other forms of_**
**_government assistance from which_**
**_the charity has directly benefited._**|**Description**
**This year**
**£**|**Description**
**This year**
**£**|**Description**
**This year**
**£**| |---|---|---|---| ||||-| ||||-| ||||-| ||||-| ||**Total**
**Description**||-| ||||**Last year**
**£**| ||||-| ||||-| ||||-| ||||-| ||**Total** -
**Thisyear**
**Lastyear**||-| ||||| ||**Thisyear**
**Lastyear**||| ||||| CC17a (Excel) 02/04/2024 15 Not applicablè CC17a (Excell 16 0210412024 ## **Section C Notes to the accounts (cont)** |**Note 5 Donated goods, facilities and services**
**Seconded staff**
**Use of property**
**Other**
**Thisyear**|**Note 5 Donated goods, facilities and services**
**Seconded staff**
**Use of property**
**Other**
**Thisyear**|**This year**
**Last year**
**£**
**£**|**This year**
**Last year**
**£**
**£**| |---|---|---|---| |||-|-| |||-|-| |||-|-| |||-|-| |||**Lastyear**|| |**Please provide details of the**
**accounting policy for the recognition**
**and valuation of donated goods,**
**facilities and services.**|||| |**Please provide details of any**
**unfulfilled conditions and other**
**contingencies attaching to resources**
**from donated goods and services not**
**recognised in income.**
**Please give details of other forms of**
**other donated goods and services not**
**recognised in the accounts, eg**
**contribution of unpaid volunteers.**|||| ||||| ||||| ||||| CC17a (Excel) 02/04/2024 17 ## **Section C Notes to the accounts (cont)** ## **Note 6 Expenditure** |**Analysis**
**Expenditure on raising funds:**|**This year**
**Last year**
**Total funds**
**Total funds**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**This year**
**Last year**
**Total funds**
**Total funds**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**This year**
**Last year**
**Total funds**
**Total funds**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**This year**
**Last year**
**Total funds**
**Total funds**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**This year**
**Last year**
**Total funds**
**Total funds**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**This year**
**Last year**
**Total funds**
**Total funds**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**This year**
**Last year**
**Total funds**
**Total funds**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**|**This year**
**Last year**
**Total funds**
**Total funds**
**£**
**£**
**Unrestricted**
**funds**
**Restricted**
**income funds**
**Endowment**
**funds**
**Unrestricted**
**funds**
**Restricted**
**income**
**funds**
**Endowment**
**funds**| |---|---|---|---|---|---|---|---|---| |Incurred seeking donations|2,392|-|-|2,392|-|-|-|-| |Incurred seeking legacies|-|-|-|-|-|-|-|-| |Incurred seeking grants|-|-|-|-|-|-|-|-| |Operating membership schemes and social
lotteries|-|-|-|-|-|-|-|-| |Staging fundraising events|22,339|-|-|22,339|-|-|-|-| |Fudraising agents|-|-|-|-|-|-|-|-| |Operating charity shops|-|-|-|-|-|-|-|-| |Operating a trading company undertaking
non-charitable tradingactivity|-|-|-|-|-|-|-|-| |Advertising, marketing, direct mail and
publicity|-|-|-|-|-|-|-|-| |Start up costs incurred in generating new
source of future income|-|-|-|-|-|-|-|-| |Database development costs|-|-|-|-|-|-|-|-| |Other trading activities|-|-|-|-|-|-|-|-| |Investment management costs:|-|-|-|-|-|-|-|-| |Portfolio management costs|-|-|-|-|-|-|-|-| |Cost of obtaining investment advice|-|-|-|-|-|-|-|-| |Investment administration costs|-|-|-|-|-|-|-|-| |Intellectual property licencing costs|-|-|-|-|-|-|-|-| |Rent collection, property repairs and
maintenance charges|-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| |**Total expenditure on raising funds**|24,731|-|-|24,731|-|-|-|-| |**Expenditure on charitable activities:**||||||||| ||-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| |**Total expenditure on charitable activities**|-|-|-|-|-|-|-|-| |**Separate material item of expense**||||||||| ||-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| |**Total**|-|-|-|-|-|-|-|-| |**Other**||||||||| ||-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| ||-|-|-|-|-|-|-|-| |**Total other expenditure**
**TOTAL EXPENDITURE**|-|-|-|-|-|-|-|-| ||24,731|-|-|24,731|-|-|-|-| CC17a (Excel) 02/04/2024 18 ## **Other information:** ## **Analysis of expenditure on charitable activities** ||**Thisyear**|**Thisyear**|**Thisyear**|**Thisyear**|**Lastyear**|**Lastyear**|**Lastyear**|**Lastyear**| |---|---|---|---|---|---|---|---|---| |**Activity or programme**|**Activities**
**undertaken**
**directly**|**Grant**
**funding of**
**activities**|**Support**
**Costs**|**Total this**
**year**|**Activities**
**undertaken**
**directly**|
**Grant**
**funding of**
**activities**|**Support**
**Costs**|**Total last**
**year**| ||**£**|**£**|**£**|**£**|**£**|**£**|**£**|**£**| |Activity1|-|-|-|-|-|-|-|-| |Activity2|-|-|-|-|-|-|-|-| |Other|-|-|-|-|-|-|-|-| |**Total**|-|-|-|-|-|-|-|-| **This year: Where sums originally denominated in foreign currency have been included in expenditure, explain the basis on which those sums have been translated into sterling (or the currency in which the accounts are drawn up). Last year: Where sums originally denominated in foreign currency have been included in expenditure, explain the basis on which those sums have been translated into sterling (or the currency in which the accounts are drawn up).** CC17a (Excel) 02/04/2024 19 ## **Section C Notes to the accounts (cont)** ## **Note 7 Extraordinary items** ## _**Please explain the nature of each extraordinary item occurring in the period.**_ |**Extraordinary item 1**
**Extraordinary item 2**
**Extraordinary item 3**
**Extraordinary item 4**
**Total extraordinary ite**|**Description**|**This year**
**Last year**
**£**
**£**|**This year**
**Last year**
**£**
**£**| |---|---|---|---| |||-|-| ||||| |||-|-| |||-|-| |||-|-| ||||| |||-|-| ||**ms**|-|-| CC17a (Excel) 02/04/2024 20 Not applicable CC17a (Excell 21 0210412024 Not applicable ## **Section C Notes to the accounts** ## **Note 8 Funds received as agent** _**8.1 Please complete this note if the charity has agreed to administer the funds of another entity as its agent. Note: If a charity is acting as an agent, it should not recognise the income in the Statement of Financial Activities or the Balance Sheet.**_ |||**Amount received**|**Amount received**|**Amountpaid out**|**Amountpaid out**|**Balance held atperiod end**|**Balance held atperiod end**| |---|---|---|---|---|---|---|---| |**Description/name of party**|**Related**
**party (Yes or**
**No)**|**Thisyear**
|**Lastyear**|**Thisyear**|**Lastyear**|**Thisyear**|**Lastyear**| |||**£**|**£**|**£**|**£**|**£**|**£**| |||-|-|-|-|-|-| |||-|-|-|-|-|-| |||-|-|-|-|-|-| |||-|-|-|-|-|-| |||-|-|-|-|-|-| |**Tota**||**l**-|-|-|-|-|-| _**8.2 Where a consortia or similar arrangement exists whereby 2 or more charities co-operate to achieve economies in the purchase of goods or services, please disclose details of any balances outstanding between any participating members.**_ |**Description/name of party**|**Balance held atperiod end**|**Balance held atperiod end**| |---|---|---| ||**Thisyear**|**Lastyear**| ||**£**|**£**| ||-|-| ||-|-| ||-|-| ||-|-| ||-|-| |**Total**|-|-| CC17a (Excel) 02/04/2024 22 ## **Section C Notes to the accounts** ## **Note 9 Support Costs** _**Please complete this note if the charity has analysed its expenses using activity categories and has support costs.**_ ## **This year** |**Support cost**
**(examples)**|**Raising funds**|**Activity 1**|**Activity 2**|**Activity 3**|**Grand total**|**Basis of allocation**| |---|---|---|---|---|---|---| ||**£**|**£**|**£**|**£**|**£**|**(Describe method)**| |Governance|1,681|-|-|-|1,681|| |Charities activities|23,600|-|-|-|23,600|| ||-|-|-|-|-|| ||-|-|-|-|-|| |Other|-|-|-|-|-|| |**Total**|25,281|-|-|-|25,281|| ## **Last year** |**Support cost**
**(examples)**|**Raising funds**
**£**|**Activity 1**
**£**|**Activity 2**
**£**|**Activity 3**
**£**|**Grand total**
**£**|**Basis of allocation**| |---|---|---|---|---|---|---| |||||||**(Describe method)**| |Governance|-|-|-|-|-|| |Charities activities|-|-|-|-|-|| ||-|-|-|-|-|| ||-|-|-|-|-|| |Other|-|-|-|-|-|| |**Total**|-|-|-|-|-|| _**Please provide details of the accounting policy adopted for the apportionment of costs between activities and any estimation techniques used to calculate their apportionment.**_ CC17a (Excel) 02/04/2024 23 ## **Section C Notes to the accounts** ## **Note 10 Details of certain types of expenditure** ## **Note 10.1 Fees for examination of the accounts** _**Please provide details of the amount paid for any statutory external scrutiny of accounts and other services provided by your independent examiner. If nothing was paid please enter '0' in the appropriate box(es).**_ |**Independent examiner’s fees**
**Assurance services other than independent examination**
**Tax advisory fees**
**Other fees (for example: financial advice, consultancy, accountancy services) paid**
**to the independent examiner**|**This year**
**£**|**Last year**
**£**| |---|---|---| ||-|-| ||-|-| ||-|-| ||-|-| CC17a (Excel) 02/04/2024 24 Not applicable CC17a IExcell 25 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 11 Paid employees** _**Please complete this note if the charity has any employees (transactions with Trustees dealt with in Note 28)**_ ## **11.1 Staff Costs** |**Salaries and wages**
**Social security costs**
**Pension costs (defined contribution scheme)**
**Other employee benefits**
**Total staff costs**
**This year:**
**Please provide details of expenditure on staff working for the**
**charity whose contracts are with and are paid by a related party**|**This year**
**£**|**Last year**
**£**| |---|---|---| ||-|-| ||-|-| |||| ||-|-| ||-|-| |||| |||| **Please provide details of expenditure on staff working for the charity whose contracts are with and are paid by a related party Last year:** **Please provide details of expenditure on staff working for the charity whose contracts are with and are paid by a related party** _**Please give details of the number of employees whose total employee benefits (excluding employer pension costs) fell within each band of £10,000 from £60,000 upwards. If there are no such transactions, please enter 'true' in the box provided.**_ ## **No employees received employee benefits (excluding employer pension costs) for the reporting period of more than £60,000** |**Band**|**Number of employees**|**Number of employees**| |---|---|---| ||**Thisyear**|**Lastyear**| |**£60,000 to £69,999**|-|-| |**£70,000 to £79,999**|-|-| |**£80,000 to £89,999**|-|-| |**£90,000 to £99,999**|-|-| |**£100,000 to £109,999**|-|-| |||| |**Please provide the total amount paid to key management**||| ||**Thisyear**|**Lastyear**| ||**£**|**£**| ||-|-| CC17a (Excel) 02/04/2024 26 **11.2 Average head count in the year The parts of the charity in which the employees work** ||**This year**
**Number**|**Last year**
**Number**| |---|---|---| |**Fundraising**|-|-| |**Charitable Activities**|-|-| |**Governance**|-|-| |**Other**|-|-| |**Total**|-|-| |**11.3 Ex-gratia payments to employees and others (excluding trustees)**
**_Please complete if an ex-gratia payment is made._**
**This year**
**Last year**
**This year**
**Last year**
**Please explain the nature of the**
**payment**
**Please state the legal authority or**
**reason for making the payment**|**11.3 Ex-gratia payments to employees and others (excluding trustees)**
**_Please complete if an ex-gratia payment is made._**
**This year**
**Last year**
**This year**
**Last year**
**Please explain the nature of the**
**payment**
**Please state the legal authority or**
**reason for making the payment**|**11.3 Ex-gratia payments to employees and others (excluding trustees)**
**_Please complete if an ex-gratia payment is made._**
**This year**
**Last year**
**This year**
**Last year**
**Please explain the nature of the**
**payment**
**Please state the legal authority or**
**reason for making the payment**| |---|---|---| ||**This year**|| ||**Last year**|| |||| ||**This year**|| ||**Last year**|| |**Please state the amount of the payment (or value of any waiver of**
**a right to an asset)**|**Thisyear**|**Lastyear**| |---|---|---| ||**£**|**£**| ||-|-| CC17a (Excel) 02/04/2024 27 ## **11.4 Redundancy payments** ## _**Please complete if any redundancy or termination payment is made in the period.**_ |**Total amount of payment**
**The extent of redundancy funding at the balance sheet date**
**The nature of the payment (cash, asset**
**etc.)**
**Please state the accounting policy for any redundancy or**
**termination payments**|**Thisyear**|**Lastyear**| |---|---|---| ||**£**|**£**| ||-|-| |||| |||| |||| ||**Thisyear**|**Lastyear**| ||**£**|**£**| ||-|-| |||| |||| CC17a (Excel) 02/04/2024 28 ## **Section C Notes to the accounts (cont)** **Note 12 Defined contribution pension scheme or defined benefit scheme accounted for as a defined contribution scheme.** ## _**12.1 Please complete this note if a defined contribution pension scheme is operated.**_ |**Amount of contributions recognised in the SOFA as an expense**
**Please explain the basis for allocating the liability and expense of**
**defined contribution pension scheme between activities and**
**between restricted and unrestricted funds.**|**Thisyear**|**Lastyear**| |---|---|---| ||**£**|**£**| ||-|-| |||| |||| ## _**12.2 Please complete this section where the charity participates in a defined benefit pension plan but is unable to ascertain its share of the underlying assets and liabilities.**_ **Please confirm that although the scheme is accounted for as a defined contribution plan, it is a defined benefit plan. Please provide such information as is available about the plan's surplus or deficit and the implications, if any, for the reporting charity this year and last year, if different** ## _**12.3 Please complete this section where the charity participates in a multi-employer defined benefit pension plan that is accounted for as a defined contribution plan.**_ **Describe the extent to which the charity can be liable to the plan for other entities' obligations under the terms and conditions of the multi-employer plan. If this is different for last year, provide details Provide an explanation of how any liability arising from an agreement with a multi-employer plan to fund a deficit has been determined. If this is different for last year, provide details** CC17a (Excel) 02/04/2024 29 Not ap￿leable CC17a (Excell 30 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 13 Grantmaking** _**Please complete this note if the charity made any grants or donations which in aggregate form a material part of the charitable activities undertaken.**_ ## **This year:** ## **13.1 Analysis of grants paid (included in cost of charitable activities)** |**Analysis**|**Grants to**
**institutions**|**Grants to**
**individuals**|**Support costs**|**Total**| |---|---|---|---|---| |Activityorproject 1|||**£**|**£**| ||Nil|Nil|Nil|Nil| |Activityorproject 2|Nil|Nil|Nil|Nil| |Activityorproject 3|Nil|Nil|Nil|Nil| |Activityorproject 4|Nil|Nil|Nil|Nil| |**_Total_**|**-**|**-**|**-**|**-**| _**Please enter “Nil” if the charity does not identify and/or allocate support costs.**_ ## **13.2 Grants made to institutions** |**_My charity has made grants to particular institutions that are material in_**
**_the context of its grantmaking. Details of the institution supported,_**
**_purpose of the grant and total paid to each institution is available on the_**
**_charity's web site._**|**_Yes_**|**_Please provide_**
**_details of charity's_**
**_URL._**| |---|---|---| ||**_No_**|**_Provide details_**
**_below_**| |**Names of institution**|**Purpose**|**Total amount of**
**grants paid £**| |---|---|---| |||-| |||-| |||-| |||-| |||-| |||-| |||-| |||-| |||-| |||-| |**_Total grants to institutions in reporting period_**
**_Other unanalysed grants_**
**_TOTAL GRANTS PAID_**||**-**| |||-| |||-| CC17a (Excel) 02/04/2024 31 ## **Last year:** ## **13.3 Analysis of grants paid (included in cost of charitable activities)** |**Analysis**|**Grants to**
**institutions**|**Grants to**
**individuals**|**Support costs**
**£**|**Total**
**£**| |---|---|---|---|---| |Activityorproject 1|Nil|Nil|Nil|Nil| |Activityorproject 2|Nil|Nil|Nil|Nil| |Activityorproject 3|Nil|Nil|Nil|Nil| |Activityorproject 4|Nil|Nil|Nil|Nil| |**_Total_**|**-**|**-**|**-**|**-**| _**Please enter “Nil” if the charity does not identify and/or allocate support costs.**_ ## **13.4 Grants made to institutions** |**13.4 Grants made to institutions**|**13.4 Grants made to institutions**||| |---|---|---|---| |**_My charity has made grants to particular institutions that are material in_**
**_the context of its grantmaking. Details of the institution supported,_**
**_purpose of the grant and total paid to each institution is available on the_**
**_charity's web site._**||**_Yes_**|**_Please provide_**
**_details of charity's_**
**_URL._**| |||**_N/a_**|**_Provide details_**
**_below_**| ||||| |**Names of institution**|**Purpose**||**Total amount of**
**grantspaid £**| ||||-| ||||-| ||||-| ||||-| ||||-| ||||-| ||||-| ||||-| ||||-| ||||-| |**_Total grants to institutions in reporting period_**
**_Other unanalysed grants_**
**_TOTAL GRANTS PAID_**|||**-**| ||||-| ||||-| CC17a (Excel) 02/04/2024 32 ## **Section C Notes to the accounts (cont)** ## **Note 14 Tangible fixed assets** ## _**Please complete this note if the charity has any tangible fixed assets**_ ## **14.1 Cost or valuation** |Additions
Revaluations
Disposals
Transfers *
At end of the year
At the beginning of the
year|**£**
**Freehold land &**
**buildings**|**£**
**Other land &**
**buildings**|**£**
**Plant, machinery and**
**motor vehicles**|**£**
**Fixtures, fittings and**
**equipment**|**Total**
**£**| |---|---|---|---|---|---| ||-
|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ## **14.2 Depreciation and impairments** |****Basis**
**** Rate**
Disposals
Depreciation
Impairment
Transfers*
At end of the year
**14.3 Net book value**
At beginning of the
year
Net book value at the
beginning of the year
Net book value at the
end of the year|SL or RB (Straight
Line or Reducing
Balance)|SL or RB|SL or RB|SL or RB|SL or RB| |---|---|---|---|---|---| ||||||| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| CC17a (Excel) 02/04/2024 33 ## **14.4 Impairment** _**This year: Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_ _**Last year: Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_ **14.5 Revaluation** _**If an accounting policy of revaluation is adopted, please provide:**_ **This year Last year** _**the effective date of the revaluation the name of independent valuer, if applicable the methods applied and significant assumptions the carrying amount that would have been recognised had**_ - - _**the assets been carried under the cost model.**_ ## **14.6 Other disclosures** |**_(i) Please state the amount of borrowing costs, if any, capitalised in the_**
**_construction of tangible fixed assets and the capitalisation rate used._**
**_(ii) Please provide the amount of contractual commitments for the acquisition of_**
**_tangible fixed assets._**
**_(iii) Details of the existence and carrying amounts of property, plant and_**
**_equipment to which the charity has restricted title or that are pledged as security_**
**_for liabilities._**|**Thisyear**|**Lastyear**| |---|---|---| ||**£**|**£**| ||-|-| ||-
|-| |||| - _The "transfers" row is for movements between fixed asset categories._ - _** Please indicate the method of depreciation by deleting the method not applicable (SL = straight line; RB = reducing balance). Also please indicate the rate of depreciation: for straight line, what is the anticipated life of the asset (in years); for reducing balance, what is_ CC17a (Excel) 02/04/2024 34 Not applitaNe CC17a (Excell 35 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 15 Intangible assets** ## _**Please complete this note if the charity has any intangible assets**_ **15.1 Cost or valuation** |Additions
Disposals
Revaluations
Transfers *
At end of the year
At beginning of the
year|**£**
**Research &**
**development**|**£**
**Patents and**
**trademarks**|**Other**
**£**|**Total**
**£**| |---|---|---|---|---| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ## **15.2 Amortisation and impairments** |****Basis**
**** Rate**
Disposals
Amortisation
Impairment
Transfers*
At end of year
At beginning of the
year|SL or RB|SL or RB|SL or RB|SL or RB|Straight Line
("SL") or
Reducing
Balance
("RB")| |---|---|---|---|---|---| ||||||| ||- - - -
- - - -
- - - -
- - - -
- - - -
- - - -||||| ||-|-|-|-|| ||-|-|-|-|| ||-|-|-|-|| ||-|-|-|-|| ||-|-|-|-|| ||-|-|-|-|| ## **15.3 Net book value** |Net book value at the
beginning of the year
Net book value at the
end of the year|-|-|-|-| |---|---|---|---|---| ||-|-|-|-| ## **15.4 Accounting policy** _**Please disclose the accounting policy for intangible fixed assets including:**_ _**Reasons for choosing amortisation rates**_ _**Policies for the recognition of any capital development**_ CC17a (Excel) 02/04/2024 36 ## **15.5 Impairment** **This year:** _**Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_ ## **Last year:** _**Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_ ## **15.6 Revaluation** _**If an accounting policy of revaluation is adopted, please provide:**_ |**_the effective date of the revaluation_**
**_the name of independent valuer, if applicable_**
**_the methods applied_**
**15.7 Other disclosures**
**_the carrying amount that would have been_**
**_recognised had the assets been carried under the_**
**_cost model._**
**_(i) If your intangible asset was acquired by way_**
**_of grant, provide value on initial recognition and_**
**_carrying amount of the asset._**
**_(ii) Details of the carrying amounts of any_**
**_intangible assets to which the charity has_**
**_restricted title or that are pledged as security for_**
**_liabilities._**
**_(iii) Please provide the amount of contractual_**
**_commitments for the acquisition of intangible_**
**_assets._**
**_(iv) State the amount of research and_**
**_development expenditure recognised as_**
**_expenditure in the year._**
**_(v) Please detail the headings in the SOFA in_**
**_which a charge for amortisation of intangible_**
**_assets is included._**
**_(vi) For any material intangible assets, please_**
**_provide a description, its carrying amount and_**
**_any remaining amortisation period._**|**This year**|**Last year**| |---|---|---| |||| |||| |||| |||| |||| |||| |||| |||| |||| |||| |||| - _The "transfers" row is for movements between fixed asset categories._ _** Please indicate the method of depreciation by deleting the method not applicable (SL = straight line; RB = reducing balance). Also please indicate the rate of depreciation: for straight line, what is the anticipated life of the asset (in years); for reducing balance, what is the percentage annual deduction._ CC17a (Excel) 02/04/2024 37 Not applicable CC17a IExcell 38 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 16 Heritage assets** ## _**Please complete this note if the charity has heritage assets**_ ## **16.1 General disclosures for all charities holding heritage assets** |**16.2 Cost or valuation**
At beginning of the year
Additions
Disposals
Revaluations
Transfers *
At end of the year
**16.3 Depreciation and impairments**
****Basis**
**** Rate**
At beginning of the year
Disposals
Depreciation
Impairment
Transfers*
At end of year
**16.4 Net book value**
Net book value at the end of the year
**(i) Explain the nature and scale of**
**heritage assets held.**
**(ii) Explain the policy for the**
**acquisition, preservation,**
**management and disposal of heritage**
**assets.**
Net book value at the beginning of the
year|**Thisyear**|**Thisyear**|**Thisyear**|**Lastyear**|**Lastyear**|**Lastyear**| |---|---|---|---|---|---|---| |||||||| |||||||| ||**Total**
**£**
**£**
**£**
**£**
**£**
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
**Heritage asset**
**1**
**Heritage asset**
**2**
**Heritage asset**
**3**
**Heritage asset**
**4**|||||| |||||||Straight Line
("SL") or
Reducing
Balance ("RB")| |||||||| ||- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -|||||| ||-|-|-|-|-|| ||-|-|-|-|-|| CC17a (Excel) 02/04/2024 39 ## **16.5 Impairment** ## **This year** _**Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_ ## **Last year** _**Please provide a description of the events and circumstances that led to the recognition or reversal of an impairment loss.**_ ## **16.6 Revaluation** _**If an accounting policy of revaluation is adopted, please provide:**_ _**the effective date of the revaluation the name of independent valuer, if applicable qualifications of independent valuer the methods applied and significant assumptions any significant limitations on the valuation**_ **This year Last year** ## **16.7 Analysis of heritage assets by class or group distinguishing those at cost and those at valuation** |Additions
Disposals
Depreciation/impairment
Revaluation
Carrying amount at the end of period
Carrying amount at the beginning of the
period|**£**
**At valuation**
**Group A**|**£**
**At cost Group**
**B**|**Total**
**£**| |---|---|---|---| ||-|-|-| ||-|-|-| ||-|-|-| ||-|-|-| ||-|-|-| ||-|-|-| ## **16.8 Heritage assets (where heritage assets are not recoignised on the balance sheet)** **(i) Explain the reason why heritage assets have not been recognised on the balance sheet. (ii) Describe the significance and nature of heritage assets.** **(iii) Disclose information that is helpful in assessing the value of heritage assets.** **This year Last year** CC17a (Excel) 02/04/2024 40 **(iv) Explain the reason why it is not practicable to obtain a valuation of heritage assets.** CC17a (Excel) 02/04/2024 41 ## **16.9 Five year summary of heritage assets transactions** ||**2015**|**2014**|**2013**|**2012**|**2011**| |---|---|---|---|---|---| ||**£**|**£**|**£**|**£**|**£**| |**Purchases**
Group A
Group B
Group C
Other
**Donations**
Group A
Group B
Group C
Other
**Total additions**
**Charge for impairment**
Group A
Group B
Group C
Other
**Total charge for impairment**
**Disposals**
Group A - carrying amount
Group B - carrying amount
Group C
Other
**Total disposals**|||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-||||| ||-||||| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||**-**|**-**|**-**|**-**|**-**| ||||||| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||**-**|**-**|**-**|**-**|**-**| ||||||| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||**-**|**-**|**-**|**-**|**-**| CC17a (Excel) 02/04/2024 42 Not applicable CC17a (Excell 43 0210412024 **Section C Notes to the accounts (cont)** ## **Note 17 Investment assets** ## _**Please complete this note if the charity has any investment assets.**_ ## **17.1 Fixed assets investments (please provide for each class of investment)** |**Less: impairments**
**Add: Reversal of impairments**
Carrying (fair) value at end of year
Carrying (fair) value at beginning of
period
**Add:**additions to investments during
period*
**Less:**disposals at carrying value
**Add/(deduct):**transfer in/(out) in the
period
**Add/(deduct):**net gain/(loss) on
revaluation|**Cash & cash**
**equivalents**|
**Listed**
**investments**|**Investment**
**properties**|**Social**
**investments**|**Other**|**Total**| |---|---|---|---|---|---|---| ||-|-|-|-|-|-| ||-|-|-|-|-|-| ||-|-|-|-|-|-| ||-|-|-|-|-|-| ||-|-|-|-|-|-| ||-|-|-|-|-|-| ||-|-|-|-|-|-| ||-|-|-|-|-|-| ***Please specify additions resulting from acquisitions through business combinations, if any.** _**Please note that Fair Value in this context is the amount for which an asset could be exchanged between knowlegable and willing parties in an arm's length transaction. For traded securities, the fair value is the value of the security quoted on the London Stock Exchange Daily Official List or equivalent. For other assets where there is no market price on a traded market, it is the trustees' or valuers' best estimate of fair value.**_ ## **17.2 Please provide a breakdown of investments shown above agreeing with the balance sheet row B04 differentiating between those held at fair value and those held at cost less impairment.** ## **This year: Analysis of investments** |**Analysis of investments**
**Cash or cash equivalents**
**Listed investments**
**Investment properties**
**Social investments**
**Total**
**Grand total (Fair value at year end+Cost less impairment)**
**Other investments**|||| |---|---|---|---| ||**Fair value at year end**|**Cost less impairment**|| ||**£**|**£**|| ||-|-|| ||-|-|| ||-|-|| ||-|-|| ||-|-|| ||-|-|| ||-||| **Last year: Analysis of investments** ## **Cash or cash equivalents** **Listed investments Investment properties Social investments** **Other investments** **Total** ||| |---|---| |**Fair value at year end**|**Cost less impairment**| |**£**|**£**| |-|-| |-|-| |-|-| |-|-| |-|-| |-|-| CC17a (Excel) 02/04/2024 44 ## **Grand total (Fair value at year end+Cost less impairment)** - ## **17.3 If your charity holds investment properties, please complete the following note:** |**(i) Explain the methods and significant assumptions in**
**determining the fair value of investment property held by the**
**charity**
**(ii) Name or independent valuer, if applicable, and relevant**
**qualifications**
**(iii) Provide details of any restrictions on the ability to realise**
**investment property or on the remittance of income or**
**disposal proceeds**
**(iv) Explain any contractual obligations for the purchase,**
**construction or development of investment property or for**
**repairs, maintenance or enhancements**|**Thisyear**|**Lastyear**| |---|---|---| |||| |||| |||| |||| ## **17.4 Please provide a breakdown of current asset investments, if applicable, agreeing with the balance h** |**Analysis of current asset investments**
**Cash or cash equivalents**
**Listed investments**
**Investment properties**
**Social investments**
**Total**
**Other investments**|**This year**|**Last year**| |---|---|---| ||**£**|**£**| ||-|-| ||-|-| ||-|-| ||-|-| ||-|-| ||-|-| ## **17.5 Guarantees** |**Please explain how the guarantee furthers the charity's aims**
**Please provide details and amount of any guarantee made to**
**or on behalf of a third party**
**Name of the entity or entities benefitting from those**
**guarantees**|**Thisyear**|**Lastyear**| |---|---|---| |||| |||| |||| CC17a (Excel) 02/04/2024 45 ## **17.6 Concessionary loans** |**17.6 Concessionary loans**||||| |---|---|---|---|---| |**Amounts payable within 1 year**
**Amounts payable after more than 1 year**
**Amounts receivable within 1 year**
**Amounts receivable after more than 1 year**
**Amount of concessionary loans made (****_Multiple_**
**_loans made may be disclosed in aggregate provided_**
**_that such aggregation does not obsure significant_**
**_information_).**
**Amount of concessionary loans received****_(Multiple_**
**_loans received may be disclosed in aggregate_**
**_provided that such aggregation does not obsure_**
**_significant information)._**
**Terms and conditions eg interest rate, security**
**provided**
**Value of any concessionary loans which have**
**been committed but not taken up at the reporting**
**date**|**_Description_**||**This year £**|**Last year £**| ||||-|-| ||||-|-| ||||-|-| ||||-|-| ||**_Total_**||-|-| |||||| ||**_Description_**||**This year £**|**Last year £**| ||||-|-| ||||-|-| ||||-|-| ||**_Total_**||-|-| |||||| ||**This year**||**Last year**|| |||||| |||||| |||||| |||||| |||||| |||||| ## **17.7 Additional information** |**Please provide information about the significance**
**of investments to the charity's financial position**
**or performance eg. terms and conditions of loans**
**or the use of hedging to manage financial risk.**
**For all investments measured at fair value, the**
**basis for determining the value, including any**
**assumptions applied when using a valuation**
**technique.**
**Where a charity has provided financial assets as a**
**form of security, the carrying amount of the**
**financial asset pledged as security and the terms**
**and conditions relating to its pledge.**
**For all investments measured at fair value, the**
**basis for determining the value, including any**
**assumptions applied when using a valuation**
**technique.**
**Where a charity has provided financial assets as a**
**form of security, the carrying amount of the**
**financial asset pledged as security and the terms**
**and conditions relating to its pledge.**|**Thisyear**|**Lastyear**| |---|---|---| ||
|| |||| |||| |||| |||| |||| CC17a (Excel) 02/04/2024 46 Not applicable CC17a (Excell 47 0210412024 Not applica ## **Section C Notes to the accounts (cont)** ## **Note 18 Stocks** ## _**Please complete this note if the charity holds any stock items**_ ## **18.1 Please state the carrying amount of stock and work in progress analysed between activities.** |**Stock**
**Donated goods**
**For resale**
**For resale**
**£**
**£**
**£**
**£**
**£**
**Charitable activities:**
**_Opening_**
- - - - -
**_Added in period_**
- - - - -
**_Expensed in period_**
- - - - -
**_Impaired_**
- - - - -
**_Closing_**
**- - - - -**
**Other trading activities:**
**_Opening_**
- - - - -
**_Added in period_**
- - - - -
**_Expensed in period_**
- - - - -
**_Impaired_**
- - - - -
**_Closing_**
**- - - - -**
**Other:**
**_Opening_**
- - - - -
**_Added in period_**
- - - - -
**_Expensed in period_**
- - - - -
**_Impaired_**
- - - - -
**_Closing_**
**- - - - -**
**Total this year**
- - - - -
**_Total previous year_**
- - - - -
**Thisyear**
**Lastyear**
**£**
**£**
**Work in**
**progress**
**For**
**distribution**
**For**
**distribution**
**18.2 Please specify the carrying amount of any**
**stocks pledged as security for liabilities**|**Stock**|**Stock**|**Donated goods**|**Donated goods**|**Work in**
**progress**| |---|---|---|---|---|---| ||**For**
**distribution**|**For resale**|**For**
**distribution**|**For resale**|| ||**£**|**£**|**£**|**£**|**£**| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||**-**|**-**|**-**|**-**|**-**| ||||||| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||**-**|**-**|**-**|**-**|**-**| ||||||| ||||||| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||-|-|-|-|-| ||**-**|**-**|**-**|**-**|**-**| ||-|-|-|-|-| ||-|-|-|-|-| ||||||| |||**Thisyear**||**Lastyear**|| |||**£**||**£**|| ||||||| CC17a (Excel) 02/04/2024 48 ble CC17a IExcell 49 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 19 Debtors and prepayments** ## _**Please complete this note if the charity has any debtors or prepayments.**_ ## **19.1 Analysis of debtors** |**Trade debtors**
**Prepayments and accrued income**
**Other debtors**
**Total**|**This year**
**£**|**Last year**
**£**| |---|---|---| ||-|-| ||-|-| ||-|-| ||-|-| ## _**Complete 19.2 where a material debtor is recoverable more than a year after the reporting date.**_ ## **19.2 Disclosure of debtors recoverable in more than 1 year (included in debtors above)** |**Trade debtors**
**Prepayments and accrued income**
**Other debtors**
**Total**|**This year**
**£**|**Last year**
**£**| |---|---|---| ||-|-| ||-|-| ||-|-| ||-|-| CC17a (Excel) 02/04/2024 50 Not applicable CC17a (Excell 51 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 20 Creditors and accruals** ## _**Please complete this note if the charity has any creditors or accruals.**_ ## **20.1 Analysis of creditors** |**Total**
**cts**|**Amounts falling due**
**within one year**|**Amounts falling due**
**within one year**|**Amounts falling due after**
**more than one year**|**Amounts falling due after**
**more than one year**| |---|---|---|---|---| ||**This year**
**£**|**Last year**
**£**|**This year**
**£**|**Last year**
**£**| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| ||-|-|-|-| **Accruals for grants payable Bank loans and overdrafts Trade creditors** **Payments received on account for contracts or performance-related grants** **Accruals and deferred income Taxation and social security Other creditors** ## **20.2 Deferred income** _**Please complete this note if the charity has deferred income**_ **This year Last year** _**Please explain the reasons why income is deferred.**_ |**_Movement in deferred income account_**
**Balance at the start of the reporting period**
**Amounts added in current period**
**Amounts released to income from previous periods**
**Balance at the end of the reporting period**|**This year**
**£**|**Last year**
**£**| |---|---|---| ||-|-| ||-|-| ||-|-| ||-|-| CC17a (Excel) 02/04/2024 52 Not applicable CC17a (Excell 53 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 21 Provisions for liabilities and charges** _**Please complete this note if you have included in charity expenditure any provisions. A provision is made when the charity has a liability of uncertain timing or amount.**_ **----- Start of picture text -----**
21.1 Movements in recognised provisions and funding commitment during the period
This year Last year
£ £
Balance at the start of the reporting period - -
Amounts added in current period - -
Amounts charged against the provision in the current period - -
Unused amounts reversed during the period - -
Balance at the end of the reporting period - -
21.2 Please provide: This year Last year
- a brief description of any obligations on the
balance sheet and the expected amount and
timing of resulting payments;
- an indication of the uncertainties about the
amount or timing of those outflows; and
- the amount of any expected reimbursement,
stating the amount of any asset that has been
recognised for that expected reimbursement.
This year Last year
21.3 For any funding commitment that is not
recognised as a liability or provision, provide
details of commitment made, the time frame of
that commitment, any performance-related
conditions and details of how the commitment
will be funded (with contracts for capital
expenditure separately identified).
21.4 Where unrestricted funds have been
designated to a fund commitment, please
disclose the nature of any amounts
designated and the likely timing of that
expenditure.
**----- End of picture text -----**
CC17a (Excel) 02/04/2024 54 Not applicable CC17a (Excell 55 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 22 Other disclosures for debtors, creditors and other basic financial instruments** |**22.1 Please provide information about the**
**significance of financial instruments (eg.**
**debtors, creditors, investments etc) to the**
**charity's financial position or performance, for**
**example, the terms and conditions of loans or**
**the use of hedging to manage financial risk.**
**22.2 If the charity has provided financial**
**assets as a form of security, the carrying**
**amount of the financial assets pledged as**
**security and the terms and conitions related to**
**its pledge should be given here.**|**This year**|**Last year**| |---|---|---| |||| |||| |||| CC17a (Excel) 02/04/2024 56 Not applicable CC17a (Excell 57 0210412024 **Section C Notes to the accounts (cont)** Not applica ## **Note 23 Contingent liabilities and contingent assets** ## **23.1 Contingent liabilities** **Where the charity has contingent liabililities, please complete the following section unless the possibility of their existence is remote.** ## **This year** |**Description of item including its legal nature.**
**Please describe any security provided in**
**connection to the liability.**|**Estimate of financial effect**| |---|---| ||| ||| ||| ||| ## **Last year** **Description of item including its legal nature. Estimate of financial effect Please describe any security provided in connection to the liability.** ## **23.2 Contingent assets** **Where the charity has contingent assets, please complete the following section when their existence is probable** ## **This year** **Description of item Estimate of financial effect** ## **Last year** ## **Description of item** ## **Estimate of financial effect** ## **23.4 Other disclosures for contingent assets and/or liabilities Please provide the following information where practicable:** **This year Last year Explain any uncertainties relating to the amount or timing of settlement; and the possibilty of any reimbursement** **Where it is not practical to make one or more of these disclosures, please state this fact** CC17a (Excel) 02/04/2024 58 ble CC17a (Excell 59 0210412024 ## **Section C Notes to the accounts (cont)** |**Note 24 Cash at bank and in hand**
**Short term cash investments (less than 3 months maturity date)**
**Short term deposits**
**Cash at bank and on hand**
**Other**
**Total**||| |---|---|---| ||**This year**
**£**|**Last year**
**£**| ||-|-| ||-|-| ||62,152|-| ||-|-| ||62,152|-| CC17a (Excel) 02/04/2024 60 Lloyds Bank ale CC17a (Excell 61 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 25 Fair value of assets and liabilities** |**25.1 Please provide details of the charity's**
**exposure to credit risk (the risk of incurring**
**a loss due to a debtor not paying what is**
**owed) , liquidity risk (the risk of not being**
**able to meet short term financial demands)**
**and market risk (the risk that the value of**
**an investment will fall due to changes in the**
**market) arising from financial instruments**
**to which the charity is exposed at the end**
**of the reporting period and explain how the**
**charity manages those risks.**
**25.2 Please give details of the amount of**
**change in the fair value of basic financial**
**instruments (debtors, creditors,**
**investments (see section 11, FRS 102**
**SORP)) measured at fair value through the**
**SoFA that is attributable to changes in**
**credit risk.**|**Thisyear**
**Lastyear**|**Thisyear**
**Lastyear**| |---|---|---| ||
|| |||| |||| CC17a (Excel) 02/04/2024 62 Noi applicable CC17a IExcell 63 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 26 Events after the end of the reporting period** _**Please complete this note events (not requiring adjustment to the accounts) have occurred after the end of the reporting period but before the accounts are authorised which relate to conditions that arose after the end of the reporting period.**_ |**Please provide details of the nature of the**
**event**
**Provide an estimate of the financial effect**
**of the event or a statement that such an**
**estimate cannot be made**|**Thisyear**
**Lastyear**|**Thisyear**
**Lastyear**| |---|---|---| |||| |||| |||| CC17a (Excel) 02/04/2024 64 Not applicable CC17a IExcell 65 0210412024 **Section C Notes to the accounts (cont)** ## **Note 27 Charity funds** ## **27.1 Details of material funds held and movements during the CURRENT reporting period** _**Please give details of the movements of material individual funds in the reporting period together with a balancing figure for 'Other funds' (which should include revaluation reserve and fair value reserve, if applicable). The 'Total funds' figure below should reconcile to 'Total funds' in the balance sheet.**_ _*** Key: PE - permanent endowment funds; EE - expendable endowment funds; R - restricted income funds, including special trusts, of the charity; and U - unrestricted funds**_ |**Fund names**|**Type PE, EE**
**R or UR ***|**Purpose and Restrictions**|**£**
**Fund**
**balances**
**brought**
**forward**|**Income**
**£**|**Expenditure**
**£**|**Transfers**
**£**|**£**
**Gains and**
**losses**|**£**
**Fund**
**balances**
**carried**
**forward**| |---|---|---|---|---|---|---|---|---| |FundraisingEvents|U|One off fundraisingamounts|-|73,044|(22,339.35)|-|-|50,705| |Donations|U|One off donations|-|13,824|(2,391.69)|-|-|11,432| |Other funds(balancingfigure)|U|One off|-|15|-|-|-|15| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| |**_Other funds(balancing figure)_ **|**N/a**|**N/a**|-|-|-|-|-|-| |**Total Funds as per balance sheet**|||-|86,883|- 24,731|-|-|62,152| **Fund balances carried forward include assets and liabilities denominated in a foreign currency** |Yes*
No*|Yes*
No*| |---|---| |ü|ü| _**If yes, please state the basis on which the assets and/or liabilities have been translated into sterling (or the currency in which the accounts are drawn up).**_ CC17a (Excel) 02/04/2024 66 **Section C Notes to the accounts (cont)** ## **Note 27 Charity funds** ## **27.2 Details of material funds held and movements during the PREVIOUS reporting period** _**Please give details of the movements of material individual funds in the reporting period together with a balancing figure for 'Other funds' (which should include revaluation reserve and fair value reserve, if applicable). The 'Total funds' figure below should reconcile to 'Total funds' in the balance sheet.**_ _*** Key: PE - permanent endowment funds; EE - expendable endowment funds; R - restricted income funds, including special trusts, of the charity; and U - unrestricted funds**_ |**_funds_**||||||||| |---|---|---|---|---|---|---|---|---| |**Fund names**|**Type PE, EE**
**R or UR ***|**Purpose and Restrictions**|**£**
**Fund**
**balances**
**brought**
**forward**|**Income**
**£**|**Expenditure**
**£**|**Transfers**
**£**|**£**
**Gains and**
**losses**|**£**
**Fund**
**balances**
**carried**
**forward**| |FundraisingEvents|U|One off fundraisingamounts|-|-|-|-|-|-| |Donations|U|One off donations|-|-|-|-|-|-| |Other funds(balancingfigure)|U|One off|-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| ||||-|-|-|-|-|-| |**_Other funds(balancing figure)_ **|**N/a**|**N/a**|-|-|-|-|-|-| |**Total Funds as per balance sheet**|||-|-|-|-|-|-| **Fund balances carried forward include assets and liabilities denominated in a foreign currency** |Yes*
No*|Yes*
No*| |---|---| |ü|ü| CC17a (Excel) 02/04/2024 67 ## **Section C Notes to the accounts (cont)** ## **Note 27 Charity funds (cont)** ## **27.3 Transfers between funds** ## **This year** |**Thisyear**||| |---|---|---| ||**Reason for transfer and where endowment is converted to income,**
**legal power for its conversion**|**Amount**| |Between unrestricted and
restricted funds||-| |Between endowment and
restricted funds||-| |Between endowment and
unrestricted funds||-| |||-| ## **Last year** ||**Reason for transfer and where endowment is converted to income,**
**legal power for its conversion**|**Amount**| |---|---|---| |Between unrestricted and
restricted funds||-| |Between endowment and
restricted funds||-| |Between endowment and
unrestricted funds||-| |||-| ## **27.4 Designated funds** |**27.4 Designated funds**|**27.4 Designated funds**|**27.4 Designated funds**| |---|---|---| |**Thisyear**||| |**Planned use**|**Purpose of the designation**|**Amount**| |||-| |||-| |||-| |||-| |||-| |||-| ## **Last year** |**Lastyear**||| |---|---|---| |**Planned use**|**Purpose of the designation**|**Amount**| |||-| |||-| |||-| |||-| |||-| |||-| CC17a (Excel) 02/04/2024 68 Not applicable CC17a (Excell 69 0210412024 ## **Section C Notes to the accounts (cont)** ## **Note 28 Transactions with trustees and related parties** _**If the charity has any transactions with related parties (other than the trustee expenses explained in guidance notes) details of such transactions should be provided in this note. If there are no transactions to report, please enter “True” in the box or "False" if there are transactions to report.**_ ## **28.1 Trustee remuneration and benefits** ## **This year** **None of the trustees have been paid any remuneration or received any other benefits from an employment with their charity or a related entity (True or False)** **1** _**In the period the charity has paid trustees remuneration and benefits. Please give the amount of, and legal authority for, any remuneration or other benefits paid to a trustee by the charity or any institution or company connected with it.**_ |**Name of trustee**|**Legal authority (eg**
**order, governing**
**document)**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**| |---|---|---|---|---|---|---| |||**Remuneration**|**Pension**
**contribution**|**Redundancy**
**(including loss**
**of office)/ex**
**gratia**|**Other**
|**TOTAL**| |||**£**|**£**|**£**|**£**|**£**| |||-|-|-|-|**-**| |||-|-|-|-|**-**| |||-|-|-|-|**-**| |||-|-|-|-|**-**| _**Please give details of why remuneration or other employment benefits were paid.**_ _**Where an ex gratia payment has been made to a trustee, provide an explanation of the nature of the payment.**_ _**If a third party has been reimbursed for providing one or more trustees, state the nature of the payment and amount of the reimbursement.**_ _**State the number of trustees to whom retirement benefits are accruing under a defined contribution pension scheme.**_ CC17a (Excel) 02/04/2024 70 **1** ## **Last year** **None of the trustees have been paid any remuneration or received any other benefits from an employment with their charity or a related entity (True or False)** _**In the period the charity has paid trustees remuneration and benefits. Please give the amount of, and legal authority for, any remuneration or other benefits paid to a trustee by the charity or any institution or company connected with it.**_ |**Name of trustee**|**Legal authority (eg**
**order, governing**
**document)**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**|**Amounts paid or benefit value**| |---|---|---|---|---|---|---| |||**Remuneration**|**Pension**
**contribution**|**Redundancy**
**(including loss**
**of office)/ex**
**gratia**|**Other**
|**TOTAL**| |||**£**|**£**||**£**|**£**| |||-|-|-|-|**-**| |||-|-|-|-|**-**| |||-|-|-|-|**-**| |||-|-|-|-|**-**| _**Please give details of why remuneration or other employment benefits were paid.**_ _**Where an ex gratia payment has been made to a trustee, provide an explanation of the nature of the payment.**_ _**If a third party has been reimbursed for providing one or more trustees, state the nature of the payment and amount of the reimbursement.**_ _**State the number of trustees to whom retirement benefits are accruing under a defined contribution pension scheme.**_ ## **28.2 Trustees' expenses** _**If the charity has paid trustees expenses for fulfilling their duties, details of such transactions should be provided in this note. If there are no transactions to report, please enter “True” in the box below. If there are transactions to report, please enter "False".**_ |**_enter "False"._**||| |---|---|---| |**No trustee expenses have been incurred (True or False)**||**_1_**| |||| |**Type of expenses reimbursed**|**This year**|**Last year**| ||**£**|**£**| |**Travel**|-|-| |**Subsistence**|-|-| |**Accommodation**|-|-| |**Other (please specify):**|-|-| ||-|-| |**TOTAL**|-|-| CC17a (Excel) 02/04/2024 71 ## **Please provide the number of trustees reimbursed for expenses or who had expenses paid by the charity** ## **28.3 Transaction(s) with related parties** _**Please give details of any transaction undertaken by (or on behalf of) the charity in which a related party has a material interest, including where funds have been held as agent for related parties. If there are no such transactions, please enter 'true' in the box provided.**_ ## **This year** **There have been no related party transactions in the reporting period (True or False)** _**1**_ |**Name of the trustee or**
**related party**|
**Relationship**
**to charity**|**Description of the**
**transaction(s)**|**Amount**|**Balance at**
**period end**|**Provision for bad debts**
**at period end**|**Amounts**
**written off**
**during**
**reporting**
**period**| |---|---|---|---|---|---|---| ||||**£**|**£**|**£**|**£**| ||||-|-|-|-| ||||-|-|-|-| ||||-|-|-|-| ||||-|-|-|-| _**In relation to the transactions above, please provide the terms and conditions, including any security and the nature of any payment (consideration) to be provided in settlement.**_ _**For any related party, please provide details of any guarantees given or received.**_ ## **Last year** **There have been no related party transactions in the reporting period (True or False)** _**1**_ |**Name of the trustee or**
**related party**|
**Relationship**
**to charity**|**Description of the**
**transaction(s)**|**Amount**|**Balance at**
**period end**|**Provision for bad debts**
**at period end**|**Amounts**
**written off**
**during**
**reporting**
**period**| |---|---|---|---|---|---|---| ||||**£**|**£**|**£**|**£**| ||||-|-|-|-| ||||-|-|-|-| ||||-|-|-|-| ||||-|-|-|-| _**In relation to the transactions above, please provide the terms and conditions, including any security and the nature of any payment (consideration) to be provided in settlement.**_ _**For any related party, please provide details of any guarantees given or received.**_ CC17a (Excel) 02/04/2024 72 **Section C Notes to the accounts (cont)** ## **Note 29 Additional Disclosures** **The following are significant matters which are not covered in other notes and need to be included to provide a proper understanding of the accounts. If there is insufficient room here, please add a separate sheet.** CC17a (Excel) 02/04/2024 73 CHARITY COMMISSION FOR ENGLAND WALES Independent examinerfs report on the accounts Section A Independent Examiner's Report Report to the trustees METUPUK (Metastatic Exchange to Unk8ash Power UK) On accouwtts for the period endad OS10412023 Charlty no lif any) 1196494 S•t out on page• I report to the trustees on my examination of the accounts of tha abov& charity Illhe Trusl'l for the p8ri0d ended OS 104 12023. Rg8pon8lbilities and bas1$ of report As the charity's trustees, you are responsible for th8 preparation of th accounts In accordance with the requirements of the Charitie5 Act 2011 I'lhe Act"). l ￿pOrt in respect of my examination of the Trust's accounts carried out under section 145 of the 2011 Act and In carrying out my examination. I have followed all the appliCat￿e D￿rectiOnS given by the Charty Commission under section 1451Sllbl of the Act. Ind8pondent examiner's statement apP1w￿l. Delete I l ifnot applic2ble. I have ¢ompl8ted rny exaM￿nation. I confimi that no matenal matters have come to my attention in connection with the examination ￿￿1￿￿.) which gives me cause ¢0 beI￿ve that in, any material respect.. th8 accounting ￿COrdS were not kept in a￿ordaI￿e ￿th section 130 of the Charities Act.. or th8 accounts did not accord wrth the acwunling ￿cOrds.. or the accounts did not comply wrth the applicable requirements concerning the form and content of accounts sel out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the ac¢ount$ give a'lrue and fair, view which is not a matter consK1e￿d as part of an independ8nl examination. I have no con￿rn$ and have come across no other matters in connection wrth th8 examination lo which attention should be drawn in this report in order to enable a proper understanding ol the accounts to be reached. ' Pl88s6 delete the wonls in the br8Gkels illh8y do not apply. Slgned: Date.. 0510212024 N*me: ALINA LORD Rel*vant professlonal quallfi¢aUc•nl$l or body FCCA IER Oct 2018 Irf anyl: Addresj: 43 High Street. Uppermill. Oldharn, OL3 6HS Section B Disclosure Only cotnplete If the examiner neecls lo highlight material matters of concern (see CC32. Independent examination of charity accounts." direc*ons and guidanc8 for examiners). Give hère brief detail• of any it8rnS that th examiner wishes to disclose. IER Oct 2018